{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-121603","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.788617+00:00","generated_at":"2026-05-29T21:04:16.657764+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Petros Pharma stockholders OK reverse stock split up to 1:25","bullets":["Directors Silverman, Bernstein, Walker elected to one-year terms.","Reverse stock split (range 1:2 to 1:25, Board discretion) approved; For 2,949,518, Against 1,350,781.","Marcum LLP ratified as independent auditor for FY2024 with 3,984,099 for votes.","Advisory say-on-pay proposal passed with 1,433,687 for votes.","Adjournment proposal passed to allow further proxy solicitation if needed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-121603","json":"https://secwatch.observer/filing/0001104659-24-121603.json","markdown":"https://secwatch.observer/filing/0001104659-24-121603.md","text":"https://secwatch.observer/filing/0001104659-24-121603.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924121603/0001104659-24-121603-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924121603/tm2429163d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:04:16.657764+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}